Aspire Biopharma Holdings, Inc. (ASBP) Revenue (2025 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Revenue of $28353.0 for Q1 2026, up 565.41% sequentially from $4261.0 in Q4 2025.
Aspire Biopharma Holdings, Inc. (ASBP) Revenue (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings has disclosed Revenue across 2 years of filings, most recently posting $28353.0 for Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,353.00 |
| Dec 31, 2025 | 4,261.00 |
| Sep 30, 2025 | 1,941.00 |